Epigenetic Mechanisms in Depression and Stress Response

Depression and stress-related disorders arise from complex interactions between genetic predispositions and environmental challenges. Epigenetic mechanisms—heritable changes in gene expression without alteration of DNA sequence—provide a molecular framework for understanding how life experiences such as chronic psychosocial stress, trauma or adversity can leave lasting marks on the brain. Key processes include DNA methylation, which typically represses gene transcription, and a spectrum of histone modifications (acetylation, methylation, serotonylation and others) that remodel chromatin structure and regulate the accessibility of transcriptional machinery. These modifications have been implicated in the regulation of stress-responsive genes, notably those controlling glucocorticoid receptor expression, neurotrophic factors (for example BDNF) and synaptic proteins. Dysregulated epigenetic landscapes can alter neuronal plasticity, synaptic strength and circuit dynamics within regions such as the hippocampus, prefrontal cortex and dorsal raphe nucleus. Through the integration of genome-wide profiling, functional imaging and behavioural paradigms, recent research has begun to map the epigenetic signatures associated with vulnerability and resilience, offering routes to biomarkers and novel therapeutics tailored to reverse maladaptive gene regulation.

Research from Nature Portfolio

Recent studies have demonstrated a non-canonical role for serotonin in directly modifying histones to influence stress-induced transcriptional programmes. Chronic social defeat in rodents leads to dysregulated serotonylation of histone H3 (H3K4me3Q5ser) within the dorsal raphe nucleus, altering expression of depression-related genes. Both pharmacological and viral-mediated interventions that normalise H3K4me3Q5ser levels attenuate stress-associated behavioural phenotypes, with parallel patterns observed in human major depressive disorder subjects on versus off antidepressant treatment. In parallel, epigenetic enhancement of antidepressant efficacy has been achieved by targeted inhibition of histone deacetylases. In fluoxetine-treated mice, selective reduction of class I and II HDAC activity augments acetylation at the BDNF promoter, boosts Bdnf transcription and potentiates both antidepressant and anxiolytic outcomes. These findings underscore histone modifications as critical mediators of both stress vulnerability and therapeutic response.

Epigenetic Mechanisms in Depression and Stress Response publication trend

The graph below shows the total number of articles in epigenetic mechanisms in depression and stress response across all publications each year (not limited to Nature Index journals).

Technical terms

Epigenetics: The study of stable and reversible changes in gene expression that do not involve alterations in the DNA sequence.

DNA methylation: The covalent addition of a methyl group to cytosine bases, often associated with transcriptional repression.

Histone modification: Post-translational changes (acetylation, methylation, phosphorylation, serotonylation) to histone proteins that influence chromatin conformation and gene expression.

HDAC (Histone deacetylase): An enzyme that removes acetyl groups from histone tails, generally leading to chromatin condensation and reduced transcription.

TET enzymes (Ten-eleven translocation): A family of dioxygenases that convert methylcytosine to hydroxymethylcytosine, promoting DNA demethylation and gene activation.

Transcriptional plasticity: The dynamic capacity of a cell to alter gene expression programmes in response to internal or external signals.

References

1. Histone serotonylation in dorsal raphe nucleus contributes to stress- and antidepressant-mediated gene expression and behavior. Nature Communications (2024).
2. Targeting Nr2e3 to Modulate Tet2 Expression: Therapeutic Potential for Depression Treatment. Advanced Science (2024).
3. The Changes of Histone Methylation Induced by Adolescent Social Stress Regulate the Resting-State Activity in mPFC. Research (2023).
4. Upregulation of HDAC9 in hippocampal neurons mediates depression-like behaviours by inhibiting ANXA2 degradation. Cellular and Molecular Life Sciences (2023).
5. An HDAC-dependent epigenetic mechanism that enhances the efficacy of the antidepressant drug fluoxetine. Scientific Reports (2015).